Central Serous Chorioretinopathy: all 84 studies

Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• A Case-Control Study Revealing Intraocular Microenvironment Characteristics in Patients With Ocular Diseases Based on Multi-Omics AnalysisNot yet recruitingNCT07897513
• Mindfulness for Central Serous ChorioretinopathyNot yet recruitingNCT07767058Not applicable
• Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled TrialNot yet recruitingNCT07681167Phase 2
• Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy PatientsNot yet recruitingNCT07347119
• Wide Field OCTA in Ocular DiseasesNot yet recruitingNCT07298174
• Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous ChorioretinopathyNot yet recruitingNCT06809751Phase 2/3
• the Study of the Association Between the Gut Microbiota and Central Serous ChorioretinopathyRecruitingNCT06527326Not applicable
• Combination of Micropulse Laser With or Without Photodynamic Therapy for Chronic Central Serous ChorioretinopathyNot yet recruitingNCT06468540
• Central Serous Chorioretinopathy and Micropulse Laser TreatmentRecruitingNCT06346405
• Steroid Eye Drops in Chronic Central Serous ChorioretinopathyRecruitingNCT05633576Phase 3
• Choroidal Blood Flow in Acute and Chronic Central Serous ChorioretinopathyRecruitingNCT05589974
• Subthreshold Nanosecond Laser for Non-resolving Central Serous ChorioretinopathyRecruitingNCT05570591Not applicable
• Biomarkers and Choroidal NeovascularizationRecruitingNCT04439708
• OCT in Rare Chorioretinal DiseasesRecruitingNCT02141308
• Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp ConfigurationsTerminatedNCT05686421Not applicableResults posted
• Sildenafil for Treatment of Choroidal IschemiaCompletedNCT04356716Phase 2Results posted
• Eplerenone for the Treatment of Central Serous ChorioretinopathyCompletedNCT01990677Not applicableResults posted
• Study on the Use of Micropulse Laser to Treat Central Serous ChorioretinopathyTerminatedNCT01982383Not applicableResults posted
• Eplerenone for Central Serous ChorioretinopathyCompletedNCT01822561Phase 2Results posted
• The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous ChorioretinopathyCompletedNCT01710332Phase 2Results posted
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOCompletedNCT01692938Results posted
• Finasteride for Chronic Central Serous ChorioretinopathyTerminatedNCT01585441Phase 2Results posted
• Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedNCT01468337Phase 1/2Results posted
• Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01325181Phase 1/2Results posted
• Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01227993Phase 1/2Results posted
• Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT00837252Phase 1/2Results posted
• Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous ChorioretinopathyCompletedNCT00803517Results posted
• Treatment of Recurrent and Multifocal Central Serous ChorioretinopathyCompletedNCT07889518Not applicable
• Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous ChorioretinopathyCompletedNCT05847049
• Two Patterns of Micropulse Laser in the Treatment of Chronic Central Serous ChorioretinopathyStatus unknownNCT05687422Not applicable
• Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSEWithdrawnNCT05679180Not applicable
• Subthreshold Micropulse Laser Treatment of Acute Central Serous ChorioretinopathyCompletedNCT05447117Not applicable
• Different Doses of vPDT in the Treatment of cCSCStatus unknownNCT05390619Not applicable
• Results of Suprachoroidal Steroids Injections in Two Chorioretinal DiseasesStatus unknownNCT05337332Phase 2/3
• Central Serous Chorioretinopathy Registry and Pachychoroid Observation and Natural History StudyActive, not recruitingNCT05278169
• Eplerenone Versus PDT: Comparative Study by OCTACompletedNCT05104138
• Crocin Supplementation in CSCRStatus unknownNCT04936490Phase 1
• Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographCompletedNCT04723160
• Pilot Study on Deep Learning in the EyeStatus unknownNCT04665102
• Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous ChorioretinopathyStatus unknownNCT04410861Not applicable
• Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich PlasmaCompletedNCT04224831Not applicable
• Optical Coherence Tomography Angiography (OCT-A) and Central Serous Chorioretinopathy (CSC)CompletedNCT03950089
• Selective Retina Therapy With 'R:GEN' in Patients With Central Serous ChorioretinopathyCompletedNCT03758963Not applicable
• The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSCStatus unknownNCT03692169
• Brinzolamide for the Treatment of Chronic Central Serous ChorioretinopathyStatus unknownNCT03542006Phase 2
• Effects of OCTA-guided PDT in Acute CSCCompletedNCT03497000Not applicable
• Selective Retina Therapy With Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean PatientsCompletedNCT03339856Not applicable
• Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous ChorioretinopathyStatus unknownNCT03079141Phase 4
• Multimodal Imaging in Central Serous ChorioretinopathyTerminatedNCT02889185Not applicable
• Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markersStatus unknownNCT02815176
• Pseudo-PDT in Central Serous ChorioretinopathyStatus unknownNCT02799992Not applicable
• Treatment Trial for Acute Central Serous ChorioretinopathyCompletedNCT02784665Not applicable
• Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous ChorioretinopathyCompletedNCT02735213Phase 2/3
• PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLiberceptStatus unknownNCT02681783Phase 4
• 577nm Micropulse Laser vs Half-dose Photodynamic Therapy on Acute Central Serous ChorioretinopathyCompletedNCT02587767Not applicable
• Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian PopulationCompletedNCT02462499Phase 4
• Short-Term Oral Mifepristone for Central Serous ChorioretinopathyCompletedNCT02354170Phase 2
• A Study of the Beneficial Effects of Eplerenone on Central Serous ChorioretinopathyStatus unknownNCT02215330Phase 2/3
• Eplerenone For the Treatment of Chronic Central Serous ChorioretinopathyStatus unknownNCT02153125Phase 2
• Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the RetinaTerminatedNCT02088151Not applicable
• Eye Patch Therapy for Central Serous Retinopathy (CSR)CompletedNCT02036632Phase 1
• Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous ChorioretinopathyCompletedNCT01971190Phase 2
• Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMDCompletedNCT01880788
• Prospective Randomized Controlled Treatment Trial for Chronic Central Serous ChorioretinopathyCompletedNCT01797861Phase 4
• Methotrexate for Central Serous Chorioretinopathy Treatment TrialStatus unknownNCT01633983Phase 2
• The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous ChorioretinopathyStatus unknownNCT01630863Not applicable
• Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)CompletedNCT01574430Phase 4
• Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous ChorioretinopathyCompletedNCT01434095Not applicable
• Central Serous Chorioretinopathy: Etiology, Course and PrognosisCompletedNCT01378130
• Micropulse Diode Laser Treatment for Chronic Central Serous ChorioretinopathyCompletedNCT01327170Not applicable
• Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNCT01256580Not applicable
• Central Serous Chorioretinopathy Treated by Modified Photodynamic TherapyCompletedNCT01019668Not applicable
• Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous RetinopathyCompletedNCT00987077Phase 2
• High-dose Antioxidants for Central Serous ChorioretinopathyCompletedNCT00963131Phase 2
• The Effect of Therapy With Bevacizumab in Chronic Central Serous ChorioretinopathyStatus unknownNCT00864773Not applicable
• Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)CompletedNCT00817245Phase 1/2
• Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)CompletedNCT00802906Not applicable
• Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave AcetateCompletedNCT00489840Phase 1/2
• Intravitreal Bevacizumab for the Treatment of Central Serous ChorioretinopathyWithdrawnNCT00418431Phase 2/3
• Selective RPE Laser Treatment (SRT) for Various Macular DiseasesStatus unknownNCT00403884Not applicable
• Intravitreal Ranibizumab Treatment of Central Serous ChorioretinopathyCompletedNCT00403325Phase 1
• Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)CompletedNCT00211445Phase 2
• A Pilot Study of the Treatment of Central Serous Chorioretinopathy With KetoconazoleCompletedNCT00211393Phase 2
• Evaluation and Treatment of Patients With Retinal DiseaseCompletedNCT00005784

← Central Serous Chorioretinopathy overview